Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Millennium Pharmaceuticals, Inc. (MLNM) -- Ignore unavailable to you. Want to Upgrade?

To: scaram(o)uche who wrote (168)	4/8/1998 11:42:00 AM
From: Biomaven	Read Replies (1) \| Respond to of 3044

Rick, Aside from the "no IND = no respect" factor, the price decline may also be explained by sales by VC's. I haven't had time to analyze the filings properly, but a quick glance indicates that a number of prior 5% shareholders now hold nothing. I don't know if these were sales or just distributions to limited partners, but seeing such distributions are often followed by sales it may not matter. I'm kind of edgy about the overall market right now, but if I were to put more money into biotechs I would add to my MLNM and ARQL holdings at these prices. Peter